Gloria Melanie

Chief Operating OfficerImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Feb 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$90K
Net Open-Market Flow
-$90K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2026Sell(S)942$28.90$27K170K
Feb 25, 2026Sell(S)859$28.16$24K171K
Feb 25, 2026Sell(S)1K$26.98$39K172K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001764013-26-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly: